Clinical Trial
Study Details
Use samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by cardiac amyloidosis and therapeutic interventions.
Study Overview
This is a prospective study enrolling patients referred for or undergoing cardiac amyloidosis or cardiovascular treatment at the University of Kentucky. The study aims to facilitate the discovery of novel diagnostic biomarkers and therapeutic targets and improve the pathophysiological understanding of cardiac amyloidosis.
Participation Criteria
Inclusion Criteria:
* All patients undergoing treatment for cardiac amyloidosis or receiving a right heart catheterization who are at least 18 years of age.
Exclusion Criteria:
* Patients without a cardiovascular or amyloidosis diagnosis, under 18 years of age.
All patients referred for or undergoing treatment for cardiac amyloidosis or receiving a right heart catheterization who are at least 18 years of age.